Correlation of ER, PR, and HER2 at the protein and mRNA levels in Asian patients with operable breast cancer
Chih‐Jung Chen(China Medical University), Kuan-Hui Shih, Ling‐Ming Tseng(National Yang Ming Chiao Tung University), Liang‐Chih Liu(National Taipei University of Technology), Ji‐An Liang(China Medical University), Chia‐Ming Hsieh(Taiwan Adventist Hospital), Jason Lei, Skye Hung-Chen Cheng(Koo Foundation Sun Yat-Sen Cancer Center), Chiun‐Sheng Huang(National Taiwan University Hospital), Ting‐Hao Chen(National Taiwan University), Po‐Sheng Yang(Mackay Memorial Hospital)
Cited by 11
Related Papers
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
|Annals of Oncology|2021|799
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Role of mitochondrial dysfunction in cancer progression
|Experimental Biology and Medicine|2016|313